Evonik declares force majeure for supply of ThreAMINO® due to Covid-19 outbreak

Due to the Covid-19 virus outbreak, Evonik’s contract manufacturer had to shut-down its production facilities. Both production and shipping of the amino acid ThreAMINO® are affected. 
 

Dr Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik, explained, “Regrettably, we are facing a supply shortage for ThreAMINO®. We have therefore decided to send a Force Majeure notification to our customers with immediate effect, in accordance with our contracts. Meanwhile, we try the utmost to mitigate this situation and re-establish supply to our customers as fast as possible.”

Evonik is keeping its customers regularly informed as the situation develops.

For more information visit the Evonik website, HERE.

 

The Global Miller
This blog is maintained by The Global Miller staff and is supported by the magazine Milling and Grain
which is published by Perendale Publishers Limited.

For additional daily news from milling around the world: global-milling.com